SCTL Societal CDMO Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SCTL

Price (delayed)

$0.3701

Market cap

$38.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.3

Enterprise value

$73.33M

Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a ...

Highlights
Societal CDMO's equity has surged by 65% YoY and by 7% QoQ
The debt has dropped by 59% year-on-year and by 2.1% since the previous quarter
SCTL's EPS is down by 25% YoY but it is up by 3.2% from the previous quarter
Societal CDMO's net income has plunged by 66% YoY and by 6% from the previous quarter
The quick ratio has contracted by 48% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.recropharma.com
Peers: OGN

Key stats

What are the main financial stats of SCTL
Market
Shares outstanding
104.79M
Market cap
$38.78M
Enterprise value
$73.33M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.57
Price to sales (P/S)
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.8
Earnings
Revenue
$91.2M
EBIT
-$9.39M
EBITDA
-$707,000
Free cash flow
-$10.78M
Per share
EPS
-$0.3
Free cash flow per share
-$0.11
Book value per share
$0.65
Revenue per share
$0.91
TBVPS
$1.07
Balance sheet
Total assets
$151.53M
Total liabilities
$93.27M
Debt
$42.7M
Equity
$58.26M
Working capital
$28.16M
Liquidity
Debt to equity
0.73
Current ratio
2.3
Quick ratio
1.06
Net debt/EBITDA
-48.87
Margins
EBITDA margin
-0.8%
Gross margin
19%
Net margin
-23.7%
Operating margin
-5.2%
Efficiency
Return on assets
-14.3%
Return on equity
-37.9%
Return on invested capital
-7.7%
Return on capital employed
-7.2%
Return on sales
-10.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SCTL stock price

How has the Societal CDMO stock price performed over time
Intraday
2.83%
1 week
4.05%
1 month
8.53%
1 year
-79.44%
YTD
-75.16%
QTD
-21.09%

Financial performance

How have Societal CDMO's revenue and profit performed over time
Revenue
$91.2M
Gross profit
$17.28M
Operating income
-$4.71M
Net income
-$21.66M
Gross margin
19%
Net margin
-23.7%
Societal CDMO's operating income has shrunk by 72% QoQ
SCTL's operating margin has dropped by 68% since the previous quarter
Societal CDMO's net income has plunged by 66% YoY and by 6% from the previous quarter
The net margin has dropped by 60% year-on-year and by 3.5% since the previous quarter

Growth

What is Societal CDMO's growth rate over time

Valuation

What is Societal CDMO stock price valuation
P/E
N/A
P/B
0.57
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.8
SCTL's EPS is down by 25% YoY but it is up by 3.2% from the previous quarter
Societal CDMO's equity has surged by 65% YoY and by 7% QoQ
SCTL's P/B is 59% below its last 4 quarters average of 1.4
SCTL's price to sales (P/S) is 73% lower than its 5-year quarterly average of 1.5 and 54% lower than its last 4 quarters average of 0.9
The revenue has grown by 3.4% YoY and by 2.2% from the previous quarter

Efficiency

How efficient is Societal CDMO business performance
Societal CDMO's ROA has plunged by 68% YoY and by 7% from the previous quarter
SCTL's return on invested capital is down by 43% since the previous quarter
SCTL's ROS is down by 23% from the previous quarter
SCTL's ROE is down by 11% YoY but it is up by 4.5% from the previous quarter

Dividends

What is SCTL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SCTL.

Financial health

How did Societal CDMO financials performed over time
SCTL's total assets is 62% greater than its total liabilities
The quick ratio has contracted by 48% YoY
Societal CDMO's current ratio has decreased by 34% YoY and by 4.6% QoQ
The debt is 27% smaller than the equity
The debt to equity has plunged by 76% YoY and by 9% from the previous quarter
Societal CDMO's equity has surged by 65% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.